Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus in advanced hormone- and chemotherapy-resistant prostate cancer
2011-002087-24Phase 2Completed
- Sponsor
- Hellenic Oncology Research Group
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temsirolimus in prostate cancer (PCa), sponsored by Hellenic Oncology Research Group. Primary endpoint: Objective Response Rate. Started Jun 2011; status: completed.
02
Drugs
temsirolimus
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2011-002087-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002087-24.